» Articles » PMID: 32562382

QRS Fragmentation As a Possible Electrocardiographic Diagnostic Marker in Patients with Acute Myocarditis: Preliminary Histopathological Validation

Overview
Journal ESC Heart Fail
Date 2020 Jun 21
PMID 32562382
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We aim to assess the reproducibility of QRS fragmentation (fQRS) on a multi-centre dataset of patients with acute myocarditis (AM), including a histopathological validation in a subgroup with biopsy-proven disease. Electrocardiogram (ECG) in patients with myocarditis is usually considered aspecific. ST changes and conduction anomalies have been commonly reported so far. We have previously described fQRS in patients with AM.

Methods And Results: Patients admitted between 2008 and 2019 in two centres with a diagnosis of AM were included. Standard ECG, echocardiography, and cardiac magnetic resonance (CMR) findings were recorded at baseline and at follow-up (FU). Eighty patients were analysed, 66 men (82%), with median age of 34 (26-43) years. Twenty-two patients had biopsy-proven AM. At presentation, 61 patients (76%) displayed fQRS. Median ejection fraction (EF) was 55% (43-60). Seventy-two patients (90%) underwent CMR and displayed late gadolinium enhancement (LGE). ECG leads showed that fQRS correlated with distribution of LGE. In patients with positive biopsy, fQRS was present in 18 (81%). Median FU was 419 days (224-956). Complete FU was available for 64 patients (80%), and 33 patients (52%) displayed persistence of fQRS. Median EF was 60% (57-64). Eleven patients underwent a repeated biopsy at FU, eight of whom had persistent inflammation and fQRS. Fifteen patients (23%) had ventricular tachycardia, 14 of whom still showed fQRS.

Conclusions: In this cohort fQRS was confirmed as an additional useful ECG sign. Persistence of fQRS was associated with ongoing inflammation and with a poorer outcome in terms of ventricular function and occurrence of arrhythmias.

Citing Articles

Pathogenic truncating filamin C mutations presenting as acute myocarditis: a case series with insights from cardiac magnetic resonance and histological analysis.

Vrettos A, Demetriades P, Ortiz M, Dominguez F, Garcia-Pavia P, Suarez-Mier M Eur Heart J Case Rep. 2024; 8(3):ytae111.

PMID: 38476289 PMC: 10928485. DOI: 10.1093/ehjcr/ytae111.


Paucisymptomatic post COVID-19 myocarditis in a young athlete during return to play workflow: possible usefulness of global longitudinal strain analysis.

De Masi De Luca G, Papadia P, Palama Z, Coluccia G BMJ Case Rep. 2024; 17(1).

PMID: 38216160 PMC: 10806975. DOI: 10.1136/bcr-2023-255863.


Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.

Marques Borges G, Sicard P, de Mello Gomides Loures C, Evangelista F, Sales C, Sabino A AAPS PharmSciTech. 2023; 24(3):79.

PMID: 36918482 DOI: 10.1208/s12249-023-02531-w.


Ultra Short Heart Rate Variability Predicts Clinical Outcomes in Patients with a Clinical Presentation Consistent with Myocarditis: A Derivation Cohort Analysis.

Perek S, Nussinovitch U, Cohen R, Gidron Y, Raz-Pasteur A J Clin Med. 2023; 12(1).

PMID: 36614887 PMC: 9821232. DOI: 10.3390/jcm12010089.


Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.

Bazoukis G, Garcia-Zamora S, Cinier G, Lee S, Gul E, Alvarez-Garcia J World J Cardiol. 2022; 14(9):483-495.

PMID: 36187429 PMC: 9523270. DOI: 10.4330/wjc.v14.i9.483.


References
1.
Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Bohm M . Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011; 13(4):398-405. DOI: 10.1093/eurjhf/hfq229. View

2.
Redfors B, Kosmidou I, Crowley A, Maehara A, Ben-Yehuda O, Arif A . Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial. Int J Cardiol. 2018; 253:20-24. DOI: 10.1016/j.ijcard.2017.10.051. View

3.
Pietrasik G, Zareba W . QRS fragmentation: diagnostic and prognostic significance. Cardiol J. 2012; 19(2):114-21. DOI: 10.5603/cj.2012.0022. View

4.
Haukilahti M, Eranti A, Kentta T, Huikuri H . QRS Fragmentation Patterns Representing Myocardial Scar Need to Be Separated from Benign Normal Variants: Hypotheses and Proposal for Morphology based Classification. Front Physiol. 2017; 7:653. PMC: 5183580. DOI: 10.3389/fphys.2016.00653. View

5.
Jain R, Singh R, Yamini S, Das M . Fragmented ECG as a risk marker in cardiovascular diseases. Curr Cardiol Rev. 2014; 10(3):277-86. PMC: 4040879. DOI: 10.2174/1573403x10666140514103451. View